| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2522 |
| Trial ID | NCT04653493 |
| Disease | B-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) |
| Year | 2020 |
| Country | Iran |
| Company sponsor | Sabz Biomedicals |
| Other ID(s) | CD19 CAR T Cells for R/R ALL |
| Cohort 1 | |||||||||
|
|||||||||